Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 10/2003

Inhalt (11 Artikel)

Original Article

Tumor immunotherapy by converting tumor cells to MHC class II–positive, Ii protein–negative phenotype

Xueqing Lu, Nikoletta L. Kallinteris, Jizhi Li, Shuzhen Wu, Yu Li, Zhong Jiang, Gilda G. Hillman, Joseph V. Gulfo, Robert E. Humphreys, Minzhen Xu

Original Article

Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer

Takashi Tsukishiro, Albert D. Donnenberg, Theresa L. Whiteside

Original Article

A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers

Govind Ragupathi, Fusataka Koide, Natarajan Sathyan, Ella Kagan, Maria Spassova, William Bornmann, Polly Gregor, Celso A. Reis, Henrik Clausen, Samuel J. Danishefsky, Philip O. Livingston

Original Article

Lymphocyte subsets and T h 1/T h 2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome

Johanna W. van Sandick, Marja A. Boermeester, Suzanne S. Gisbertz, Ineke J. M. ten Berge, Theo A. Out, Tineke C. T. M. van der Pouw Kraan, J. Jan B. van Lanschot

Original Article

The effects of αGalCer-induced TCRVα24 Vβ11+ natural killer T cells on NK cell cytotoxicity in umbilical cord blood

Yoko Ueda, Masao Hagihara, Balgansuren Gansuvd, Ying Yu, Aya Masui, Ayako Okamoto, Ayako Higuchi, Kei Tazume, Syunichi Kato, Tomomitsu Hotta

Original Article

Tumor mRNA–loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma

Tsutomu Kobayashi, Ryuya Yamanaka, Junpei Homma, Naoto Tsuchiya, Naoki Yajima, Seiichi Yoshida, Ryuichi Tanaka

Original Article

Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients

L. G. Durrant, M. A. Chapman, D. J. Buckley, I. Spendlove, R. A. Robins, N. C. Armitage

Original Article

Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells

Laura Sanz, Mónica Feijóo, Belén Blanco, Antonio Serrano, Luis Álvarez-Vallina

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.